QuantRx Biomedical Corporation Financial Ratios — QTXB Stock

Profitability (USD)

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-151.8	-218.88	-132.83	67.82	-92.51	-135.43	-82.19	-186.16	-110.19	-139.37	108.41	-74.71	-172.96	-262.2	-847.35
Return on Capital (%)	- -	- -	- -	-1.77	- -	- -	- -	- -	- -	- -	-2.31	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	-768.07	- -	- -	- -	- -	- -	- -	-27.26	- -	- -	- -	- -
Gross Margin (%)	99.46	90.09	98.91	99.41	97.86	97.73	90.41	18.6	100	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-762.07	-867.3	-90.6	-3,053.29	-3,997.28	-3,176.36	-6,016.31	-18,634.44	-223,746.15	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-801.5	-912.69	-94.23	-3,148.41	-4,174.82	-3,244.21	-6,166.55	-19,032.18	-229,941.67	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-140,942.31	- -	- -	- -	- -	- -
Pretax Margin (%)	-864.98	-1,269.62	-123.6	1,402.72	-2,904.47	-4,712.31	-5,861.79	-34,032.3	-299,858.97	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-809.02	-1,236.42	-123.6	1,304.5	-4,105.93	-4,712.31	-5,861.79	-34,032.3	-299,858.97	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-809.02	-1,236.42	-123.6	695.53	-4,105.93	-4,712.31	-5,861.79	-34,032.3	-299,858.97	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	-76.72	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021

Total Debt	1	4	- -	- -	- -	- -	1	1	1	2	2	2	2	2	3
ST Debt	1	4	- -	- -	- -	- -	1	1	1	2	2	2	2	2	3
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.15	-0.73	-0.02	-0.02	-0.28	-0.95	-2.13	-1.33	-3.87	-12.87	-12.61	-8.51	-10.92	-39.92	-60.78
Net Debt/EBITDA	-0.11	-0.7	0.14	0.1	-0.27	-0.93	-2.12	-0.85	-3.7	-12.86	-9.63	-7.14	-10.28	-39.01	-60.64
Total Debt/EBIT	-0.14	-0.7	-0.02	-0.02	-0.27	-0.93	-2.08	-1.3	-3.77	-12.2	-11.78	-8.51	-10.92	-39.92	-60.78
Net Debt/EBIT	-0.11	-0.67	0.14	0.09	-0.26	-0.91	-2.06	-0.83	-3.6	-12.2	-8.99	-7.14	-10.28	-39.01	-60.64
EBITDA to Interest Expense	- -	-14.64	-4.97	-264.72	-117.35	-3.43	-6.46	-4.33	-2.82	-0.67	-0.63	-1.02	-1.02	-0.28	-0.2
EBITDA-CapEx/Interest Expense	- -	-15.12	-5.57	-264.72	-117.35	-3.47	-6.46	-4.33	-2.82	-0.67	-0.63	-1.02	-1.02	-0.28	-0.2
EBIT to Interest Expense	- -	-15.41	-5.17	-272.97	-122.56	-3.51	-6.62	-4.42	-2.9	-0.71	-0.67	-1.02	-1.02	-0.28	-0.2
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-1,012.73	-1,312.34	-3,559.27	-4,264.85	-8,183.01	-10,276.58	-12,321.38	-10,167.63	-14,023.42	-23,793.03	-3,574.66	-8,672.12	-37,185.96	-92,603.06	-867,026.29
Long-Term Debt/Equity (%)	2.7	- -	- -	9.64	32.57	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-0.14	-0.11	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.08	-0.07	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	1.36	1.29	3.28	3.97	7.51	9.28	11.06	8.52	11	16.77	- -	- -	- -	- -	- -
Total Debt/Equity (%)	46.56	-126.81	-201.06	9.64	157.04	-121.61	-113.46	-49.67	-94.37	-100.93	-259.59	-133.19	-103.53	-101.64	-99.84
Total Debt/Capital (%)	-2.37	-9.75	-0.09	-0.09	-0.45	-0.96	-1.63	-1.23	-2.77	-3.48	-4.09	-4.15	-4.51	-4.95	-5.39
Total Debt/Total Assets (%)	23.45	116.64	3.28	3.97	36.19	97.37	196.68	123.03	376.98	796.82	139.9	344.87	1,604.25	4,366.33	44,316.44
Net Debt to Equity	34.95	-121.37	1,518.05	-40.75	151.44	-118.98	-112.81	-31.68	-90.1	-100.89	-198.2	-111.82	-97.41	-99.31	-99.61
Net Debt/Capital (%)	-1.77	-9.3	0.69	0.39	-0.43	-0.94	-1.62	-0.78	-2.64	-3.48	-3.09	-3.46	-4.24	-4.84	-5.38
EBITDA	-6	-5	-2	-2	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx	-6	-6	-3	-2	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-6	-6	-2	-2	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Liquidity (USD)

API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021

Cash Ratio	0.12	0.03	0.28	0.38	0.02	0.01	- -	0.13	0.03	- -	0.4	0.15	0.06	0.02	- -
Current Ratio	0.5	0.11	0.63	0.86	0.76	0.29	0.15	0.16	0.08	0.02	0.42	0.17	0.06	0.02	- -
Quick Ratio	0.29	0.07	0.53	0.82	0.72	0.26	0.12	0.13	0.03	- -	0.4	0.15	0.06	0.02	- -
CFO/Avg Current Liab	-4.68	-0.68	-0.29	-1.9	-0.84	-0.3	-0.16	-0.22	-0.13	-0.05	-0.08	-0.12	-0.09	-0.03	-0.02
Common Equity/Total Assets	-1,012.73	-1,312.34	-3,559.27	-4,264.85	-8,183.01	-10,276.58	-12,321.38	-10,167.63	-14,023.42	-23,793.03	-3,574.66	-8,672.12	-37,185.96	-92,603.06	-867,026.29
Long-Term Debt/Equity (%)	2.7	- -	- -	9.64	32.57	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-0.14	-0.11	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.08	-0.07	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	1.36	1.29	3.28	3.97	7.51	9.28	11.06	8.52	11	16.77	- -	- -	- -	- -	- -
Total Debt/Equity (%)	46.56	-126.81	-201.06	9.64	157.04	-121.61	-113.46	-49.67	-94.37	-100.93	-259.59	-133.19	-103.53	-101.64	-99.84
Total Debt/Capital (%)	-2.37	-9.75	-0.09	-0.09	-0.45	-0.96	-1.63	-1.23	-2.77	-3.48	-4.09	-4.15	-4.51	-4.95	-5.39
Total Debt/Total Assets (%)	23.45	116.64	3.28	3.97	36.19	97.37	196.68	123.03	376.98	796.82	139.9	344.87	1,604.25	4,366.33	44,316.44
CFO/Total Liabilities	-275.19	-42.86	-81.75	-281.42	-94.73	-21.33	-13.75	-17.12	-12.64	-5	-7.04	-12.35	-8.46	-3.08	-1.87
CFO/CapEx	-18.78	-15.76	-4.02	- -	- -	-33.26	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-39.36	-62.06	-49.99	-66.42	-124.73	-158.77	-198.25	-158.96	-219.39	-375.07	-52.17	-128.15	-551.99	-1,371.36	-12,880.08

Working Capital (USD)

API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021

Accounts Receivable Turnover	16.3	9.87	43.1	1.65	4.45	4.72	3.76	3.83	0.89	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	22.39	36.97	8.47	220.79	82.03	77.32	97.06	95.31	411.79	- -	- -	- -	- -	- -	- -
Inventory Turnover	0.22	1.6	1.24	0.09	0.12	0.13	0.26	2	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	1,678.9	228.36	293.67	4,112.82	2,980.68	2,887.3	1,414.53	182.5	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.09	0.04	-0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	4,258.31	8,250.92	-70,918.82	-404,091.77	-267,134.27	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	-2,557.02	-7,985.58	71,220.95	408,425.38	270,196.99	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	-1,656.51	-191.39	-285.2	-3,892.03	-2,898.66	-2,809.98	-1,317.47	-87.19	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021

Market Capitalization	28	15	17	3	4	4	2	3	2	1	- -	- -	- -	- -	1
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	4	- -	- -	- -	- -	1	1	1	2	2	2	2	2	3
Enterprise Value	29	19	16	3	4	4	3	3	3	2	2	2	2	3	3
Total Capital	-36	-41	-48	-47	-48	-48	-48	-49	-49	-49	-48	-48	-49	-49	-49
Total Debt/Capital (%)	-2.37	-9.75	-0.09	-0.09	-0.45	-0.96	-1.63	-1.23	-2.77	-3.48	-4.09	-4.15	-4.51	-4.95	-5.39
Total Debt / EV	0.03	0.21	- -	0.01	0.05	0.1	0.31	0.17	0.41	0.71	1.12	1.04	0.91	0.83	0.76
EV/Sales	38.38	29.7	6.39	50.1	206.11	289.61	418.66	1,437.03	20,908.76	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.37	18.33	- -	372.81	20.44	20.81
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.37	18.33	- -	372.81	20.44	20.81
Diluted Market Cap	28	15	17	3	4	4	2	3	2	1	1	- -	- -	- -	1
Diluted Enterprise Value	29	19	16	3	4	4	3	3	3	2	2	2	2	3	3
EV per Share	0.71	0.44	0.37	0.07	0.08	0.09	0.05	0.06	0.05	0.03	0.02	0.02	0.03	0.04	0.04
TTM Sales	1	1	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-6	-5	-2	-2	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Operating Income	-6	-6	-2	-2	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Cash Flow to Firm	-5	-2	-1	-2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Free Cash Flow to Firm	-5	-2	- -	-2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Multiples (USD)

API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021

Price/Free Cash Flow	-5.94	-5.62	-19.8	-1.74	-8.25	-21.27	-10.55	-10.07	-7.97	-5.41	-5.37	-0.7	-1.52	-6.3	-15.91
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	29	19	16	3	4	4	3	3	3	2	2	2	2	3	3
Low Price	0.43	0.2	0.18	0.03	0.04	0.08	0.01	0.01	0.02	0.01	- -	- -	- -	- -	0.01
EV/Sales	38.38	29.7	6.39	50.1	206.11	289.61	418.66	1,437.03	20,908.76	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	7.22	- -	- -	- -	- -	- -	- -	0.56	- -	- -	- -	- -
Price/Earnings Average	-7	-3.55	-5.06	21.08	-3.64	-5.23	-9.12	-4.62	-4.81	-2.78	0.72	-0.74	-0.51	-1.44	-4.09
Price/Earnings High	-10.75	-6.06	-8.17	44.61	-5.4	-5.23	-11	-7.47	-11.42	-5.41	1.99	-2.14	-1.01	-4.33	-7.14
Price/Earnings Low	-2.89	-1.1	-2.49	3.01	-2.1	-5.23	-1.03	-0.85	-2.29	-1.21	0.23	-0.25	-0.29	-0.87	-1.62
Price/Book Value	-0.76	-0.33	-0.35	-0.07	-0.07	-0.08	-0.03	-0.06	-0.04	-0.01	-0.01	- -	-0.01	-0.01	-0.02
Price/Book Value Average	-1.14	-0.61	-0.33	-0.2	-0.06	-0.08	-0.07	-0.08	-0.04	-0.02	-0.01	-0.01	-0.01	-0.01	-0.02
Price/Book Value High	-1.76	-1.05	-0.54	-0.42	-0.09	-0.08	-0.08	-0.12	-0.11	-0.04	-0.03	-0.03	-0.01	-0.02	-0.04
Price/Book Value Low	-0.47	-0.19	-0.16	-0.03	-0.03	-0.08	-0.01	-0.01	-0.02	-0.01	- -	- -	- -	- -	-0.01
Price/Tangible Book Value	-86.69	-2.87	-135.74	13.89	-32.5	-6.1	-1.69	-2.08	-1.11	-0.28	-0.53	-0.12	-0.13	-0.19	-0.29
Price/Tangible Book Value Average	-130.9	-5.32	-130.41	40.56	-26.29	-6.1	-3.51	-2.71	-1.39	-0.6	-0.68	-0.35	-0.15	-0.15	-0.39
Price/Tangible Book Value High	-201.02	-9.09	-210.76	85.85	-39	-6.1	-4.23	-4.38	-3.3	-1.16	-1.89	-1	-0.29	-0.45	-0.69
Price/Tangible Book Value Low	-54.02	-1.65	-64.3	5.79	-15.17	-6.1	-0.4	-0.5	-0.66	-0.26	-0.21	-0.12	-0.08	-0.09	-0.16
Price/Sales	37.52	23.61	6.51	50.2	184.69	246.57	257.96	1,209.99	11,567.54	- -	- -	- -	- -	- -	- -
Price/Sales Average	56.65	43.86	6.25	146.58	149.43	246.57	534.48	1,571.8	14,417.09	- -	- -	- -	- -	- -	- -
Price/Sales High	87.01	74.89	10.1	310.28	221.63	246.57	644.89	2,540.97	34,231.35	- -	- -	- -	- -	- -	- -
Price/Sales Low	23.38	13.56	3.08	20.92	86.19	246.57	60.19	290.4	6,854.84	- -	- -	- -	- -	- -	- -
Price/Cash Flow	-5.62	-5.26	-14.87	-1.74	-8.25	-20.63	-10.55	-10.07	-7.97	-5.41	-3.24	-0.7	-1.52	-6.3	-15.91
Price/Cash Flow Average	-8.49	-9.78	-14.29	-5.09	-6.67	-20.63	-21.85	-13.08	-9.94	-11.69	-4.13	-2.11	-1.67	-4.87	-21.52
Price/Cash Flow High	-13.04	-16.7	-23.09	-10.78	-9.9	-20.63	-26.36	-21.15	-23.59	-22.75	-11.5	-6.1	-3.28	-14.6	-37.54
Price/Cash Flow Low	-3.5	-3.02	-7.04	-0.73	-3.85	-20.63	-2.46	-2.42	-4.72	-5.1	-1.31	-0.7	-0.94	-2.94	-8.51
Price/Free Cash Flow Average	-8.97	-10.44	-19.02	-5.09	-6.67	-21.27	-21.85	-13.08	-9.94	-11.69	-6.85	-2.11	-1.67	-4.87	-21.52
Price/Free Cash Flow High	-13.77	-17.83	-30.74	-10.78	-9.9	-21.27	-26.36	-21.15	-23.59	-22.75	-19.05	-6.1	-3.28	-14.6	-37.54
Price/Free Cash Flow Low	-3.7	-3.23	-9.38	-0.73	-3.85	-21.27	-2.46	-2.42	-4.72	-5.1	-2.17	-0.7	-0.94	-2.94	-8.51
EV/Sales Average	57.52	49.94	6.14	146.48	170.85	289.61	695.19	1,798.84	23,758.31	- -	- -	- -	- -	- -	- -
EV/Sales High	87.87	80.98	9.99	310.18	243.05	289.61	805.6	2,768.01	43,572.57	- -	- -	- -	- -	- -	- -
EV/Sales Low	24.24	19.65	2.97	20.81	107.61	289.61	220.9	517.43	16,196.06	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-7.55	-5.76	-6.77	-4.8	-4.27	-9.12	-11.56	-9.65	-10.62	-22.53	-14.74	-9.71	-12.17	-46.05	-86.61
EV/EBITDA High	-11.53	-9.34	-11.02	-10.16	-6.08	-9.12	-13.39	-14.85	-19.47	-30.48	-21.93	-14.08	-13.7	-58.07	-104.88
EV/EBITDA Low	-3.18	-2.27	-3.27	-0.68	-2.69	-9.12	-3.67	-2.78	-7.24	-17.79	-11.98	-8.17	-11.48	-43.66	-71.78
EV/EBIT Average	-7.18	-5.47	-6.51	-4.65	-4.09	-8.93	-11.27	-9.45	-10.33	-21.37	-13.77	-9.71	-12.17	-46.05	-86.61
EV/EBIT High	-10.96	-8.87	-10.6	-9.85	-5.82	-8.93	-13.06	-14.54	-18.95	-28.91	-20.49	-14.08	-13.7	-58.07	-104.88
EV/EBIT Low	-3.02	-2.15	-3.15	-0.66	-2.58	-8.93	-3.58	-2.72	-7.04	-16.87	-11.2	-8.17	-11.48	-43.66	-71.78
Last Price	0.69	0.35	0.38	0.07	0.08	0.08	0.03	0.05	0.03	0.01	0.01	- -	- -	0.01	0.01
High Price	1.6	1.11	0.59	0.44	0.09	0.08	0.08	0.1	0.08	0.03	0.02	0.02	0.01	0.01	0.02
Enterprise Value Average	43	31	16	9	3	4	4	4	4	3	2	2	2	3	4
Enterprise Value High	66	51	25	20	5	4	5	7	7	4	3	3	3	4	5
Enterprise Value Low	18	12	8	1	2	4	1	1	3	2	2	2	2	3	3

Shares Outstanding	42	43	44	44	47	53	53	63	70	79	79	79	79	79	79
Diluted Weighted Avg Shares	41	42	44	44	47	50	53	59	67	74	130	79	79	79	79
Basic Weighted Avg Shares	41	42	44	44	47	50	53	59	67	74	79	79	79	79	79
Revenue per Share	0.02	0.01	0.06	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-0.14	-0.13	-0.05	-0.04	-0.02	-0.01	-0.01	-0.01	-0.01	- -	- -	- -	- -	- -	- -
Operating Income per Share	-0.15	-0.14	-0.06	-0.05	-0.02	-0.01	-0.01	-0.01	-0.01	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	-0.15	-0.18	-0.07	0.01	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01	0.01	-0.01	-0.01	- -	- -
Basic EPS from Cont Ops	-0.15	-0.19	-0.07	0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	0.01	-0.01	-0.01	- -	- -
Diluted EPS, GAAP	-0.15	-0.18	-0.07	0.01	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01	0.01	-0.01	-0.01	- -	- -
Diluted EPS from Cont Ops	-0.15	-0.19	-0.07	0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	0.01	-0.01	-0.01	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.12	-0.07	-0.03	-0.04	-0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	-0.13	-0.07	-0.03	-0.04	-0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	0.01	- -	0.01	0.01	- -	- -	- -	- -	- -	- -	0.01	- -	- -	- -	- -
Book Value per Share	-0.91	-1.06	-1.09	-1.06	-1.02	-0.97	-0.93	-0.85	-0.75	-0.68	-0.63	-0.64	-0.65	-0.65	-0.66
Tangible Book Value per Share	-0.01	-0.12	- -	0.01	- -	-0.01	-0.02	-0.02	-0.02	-0.03	-0.01	-0.02	-0.03	-0.03	-0.03

QuantRx Biomedical Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)